Julie Ann Sosa MD, MA, FACS

Julie Ann Sosa, MD MA FACS is Chief of Endocrine Surgery at Duke University and leader of the endocrine neoplasia diseases group in the Duke Cancer Institute and the Duke Clinical Research Institute. She is Professor of Surgery and Medicine. Her clinical interest is in endocrine surgery, with a focus in thyroid cancer. She is widely published in outcomes analysis, as well as cost-effectiveness analysis, meta-analysis, and survey-based research, and she is director of health services research for Duke Surgery. Her research group is multi-disciplinary, and she has collaborators in health services research and outcomes, biostatistics, geriatrics, endocrinology, oncology, vascular surgery, breast surgery, pharmacology and cancer biology, and stem cell research.

She is a member of the Board of Directors of the International Thyroid Oncology Group, and has been a PI or investigator in a number of clinical trials for advanced thyroid cancer. She is Deputy Editor of JAMA-Surgery, and is on the editorial boards of the Annals of Surgery, Annals of Surgical Oncology, Endocrine, Hormones and Cancer, Journal of Thyroid Research, and the International Journal of Endocrine Oncology. She is Associate Editor of the World Journal of Surgery and the Journal of Surgical Research, and is editor of the endocrine tumors section of Current Opinion in Oncology. She has served on ATA guidelines committees for hyperthyroidism and thyroid nodules and differentiated thyroid cancer, and on the NCCN guidelines committee for neuroendocrine tumors.